A new technique which slashes the time taken to diagnose microbial infections from days to minutes could help save lives and ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

Atea continues to advance its global Phase 3 program evaluating the fixed-dose combination (FDC) of BEM, a nucleotide analog ...